ImpediMed Limited (ASX:IPD)
Australia · Delayed Price · Currency is AUD 0.0050
0.00 (0.00%)
Jun 26, 2026, 2:54 PM AEST
ImpediMed Market Cap
ImpediMed has a market cap or net worth of 11.69 million as of June 26, 2026. Its market cap has decreased by -80.78% in one year.
Market Cap
11.69M
Enterprise Value
14.40M
Revenue
14.23M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.01
Market Cap Chart
Since October 24, 2007, ImpediMed's market cap has decreased from 67.49M to 11.69M, a decrease of -82.68%. That is a compound annual growth rate of -8.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 11.69M | -83.13% |
| Dec 31, 2025 | 69.30M | -34.16% |
| Dec 31, 2024 | 105.26M | -64.12% |
| Dec 29, 2023 | 293.38M | 108.23% |
| Dec 30, 2022 | 140.90M | -54.66% |
| Dec 31, 2021 | 310.77M | 130.93% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Control Bionics | 33.78M |
| CleanSpace Holdings | 31.56M |
| Nova Eye Medical | 29.91M |
| Micro-X | 23.94M |
| Memphasys | 21.61M |
| OncoSil Medical | 20.72M |
| Atomo Diagnostics | 15.34M |
| CONNEQT Health | 14.16M |